 AUSTIN, Texas--BUSINESS WIRE--Genprex, Inc. Genprex or the Company NASDAQ: GNPX, a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its President and Chief Executive Officer, Rodney Varner, will be participating in two investor conferences in September 2021. CEO Roadshow Webinar Format: Company presentation Presentation DateTime: September 22, 2021 at 11:00 a.m. ET Access: 